Literature DB >> 33712616

Bi-allelic MCM10 variants associated with immune dysfunction and cardiomyopathy cause telomere shortening.

Wendy Leung1, Megan M Schmit1, Jacob Peter Matson2, Ryan M Baxley1, Lulu Yin1, Marissa K Oram1, Liangjun Wang1, John Taylor3, Jack Hedberg1, Colette B Rogers1, Adam J Harvey1, Debashree Basu1, Jenny C Taylor4,5, Alistair T Pagnamenta4,5, Helene Dreau6, Jude Craft7, Elizabeth Ormondroyd8, Hugh Watkins8, Eric A Hendrickson1, Emily M Mace9, Jordan S Orange9, Hideki Aihara1, Grant S Stewart10, Edward Blair7, Jeanette Gowen Cook2, Anja-Katrin Bielinsky11.   

Abstract

Minichromosome maintenance protein 10 (MCM10) is essential for eukaryotic DNA replication. Here, we describe compound heterozygous MCM10 variants in patients with distinctive, but overlapping, clinical phenotypes: natural killer (NK) cell deficiency (NKD) and restrictive cardiomyopathy (RCM) with hypoplasia of the spleen and thymus. To understand the mechanism of MCM10-associated disease, we modeled these variants in human cell lines. MCM10 deficiency causes chronic replication stress that reduces cell viability due to increased genomic instability and telomere erosion. Our data suggest that loss of MCM10 function constrains telomerase activity by accumulating abnormal replication fork structures enriched with single-stranded DNA. Terminally-arrested replication forks in MCM10-deficient cells require endonucleolytic processing by MUS81, as MCM10:MUS81 double mutants display decreased viability and accelerated telomere shortening. We propose that these bi-allelic variants in MCM10 predispose specific cardiac and immune cell lineages to prematurely arrest during differentiation, causing the clinical phenotypes observed in both NKD and RCM patients.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33712616      PMCID: PMC7955084          DOI: 10.1038/s41467-021-21878-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  72 in total

Review 1.  Human gene essentiality.

Authors:  István Bartha; Julia di Iulio; J Craig Venter; Amalio Telenti
Journal:  Nat Rev Genet       Date:  2017-10-30       Impact factor: 53.242

2.  Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.

Authors:  Judy M Y Wong; Kathleen Collins
Journal:  Genes Dev       Date:  2006-10-02       Impact factor: 11.361

3.  Targeted disruption of Mcm10 causes defective embryonic cell proliferation and early embryo lethality.

Authors:  Han Jeong Lim; Yoon Jeon; Chang Hwan Jeon; Jong Hyun Kim; Ho Lee
Journal:  Biochim Biophys Acta       Date:  2011-06-15

Review 4.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

5.  Regulated eukaryotic DNA replication origin firing with purified proteins.

Authors:  Joseph T P Yeeles; Tom D Deegan; Agnieszka Janska; Anne Early; John F X Diffley
Journal:  Nature       Date:  2015-03-04       Impact factor: 49.962

6.  Xenopus Mcm10 is a CDK-substrate required for replication fork stability.

Authors:  Gaganmeet Singh Chadha; Agnieszka Gambus; Peter J Gillespie; J Julian Blow
Journal:  Cell Cycle       Date:  2016-06-21       Impact factor: 4.534

7.  Clinical and Molecular Heterogeneity of RTEL1 Deficiency.

Authors:  Carsten Speckmann; Sushree Sangita Sahoo; Marta Rizzi; Shinsuke Hirabayashi; Axel Karow; Nina Kathrin Serwas; Marc Hoemberg; Natalja Damatova; Detlev Schindler; Jean-Baptiste Vannier; Simon J Boulton; Ulrich Pannicke; Gudrun Göhring; Kathrin Thomay; J J Verdu-Amoros; Holger Hauch; Wilhelm Woessmann; Gabriele Escherich; Eckart Laack; Liliana Rindle; Maximilian Seidl; Anne Rensing-Ehl; Ekkehart Lausch; Christine Jandrasits; Brigitte Strahm; Klaus Schwarz; Stephan R Ehl; Charlotte Niemeyer; Kaan Boztug; Marcin W Wlodarski
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

8.  Telomere shortening is a hallmark of genetic cardiomyopathies.

Authors:  Alex C Y Chang; Andrew C H Chang; Anna Kirillova; Koki Sasagawa; Willis Su; Gerhard Weber; Jue Lin; Vittavat Termglinchan; Ioannis Karakikes; Timon Seeger; Alexandra M Dainis; John T Hinson; Jonathan Seidman; Christine E Seidman; John W Day; Euan Ashley; Joseph C Wu; Helen M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-27       Impact factor: 11.205

9.  Uncoupling fork speed and origin activity to identify the primary cause of replicative stress phenotypes.

Authors:  Sara Rodriguez-Acebes; Silvana Mourón; Juan Méndez
Journal:  J Biol Chem       Date:  2018-06-29       Impact factor: 5.157

10.  The mechanism of eukaryotic CMG helicase activation.

Authors:  Max E Douglas; Ferdos Abid Ali; Alessandro Costa; John F X Diffley
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

View more
  3 in total

1.  Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Charlotte Cunningham-Rundles; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Eric Oksenhendler; Capucine Picard; Anne Puel; Jennifer Puck; Mikko R J Seppänen; Raz Somech; Helen C Su; Kathleen E Sullivan; Troy R Torgerson; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2022-06-24       Impact factor: 8.542

2.  Comprehensive analysis of DNA replication timing across 184 cell lines suggests a role for MCM10 in replication timing regulation.

Authors:  Madison Caballero; Tiffany Ge; Ana Rita Rebelo; Seungmae Seo; Sean Kim; Kayla Brooks; Michael Zuccaro; Radhakrishnan Kanagaraj; Dan Vershkov; Dongsung Kim; Agata Smogorzewska; Marcus Smolka; Nissim Benvenisty; Stephen C West; Dieter Egli; Emily M Mace; Amnon Koren
Journal:  Hum Mol Genet       Date:  2022-08-25       Impact factor: 5.121

Review 3.  Novel Genetic Discoveries in Primary Immunodeficiency Disorders.

Authors:  Margaret T Redmond; Rebecca Scherzer; Benjamin T Prince
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-12       Impact factor: 10.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.